M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladder.
Bellmunt J, Ribas A, Albanell J, Bermejo B, Vera R, De Torres JA, Morote J, Lopez-Pacios MA, Banus JM, Rovirosa A, Carulla J, Sole LA.
Bellmunt J, et al. Among authors: albanell j.
Am J Clin Oncol. 1996 Aug;19(4):344-8. doi: 10.1097/00000421-199608000-00004.
Am J Clin Oncol. 1996.
PMID: 8677901
Clinical Trial.